Literature DB >> 12037129

Different pathways of cell killing by gossypol enantiomers.

Jianping Qiu1, Lonny R Levin, Jochen Buck, Marcus M Reidenberg.   

Abstract

Gossypol, a polyphenolic, aldehyde-containing constituent of cottonseed, produced partial responses (>50% reduction in tumor size) in some patients with advanced cancer and suppressed sperm as an antifertility agent for men. This action in vivo and its novel side effect profile suggest a specific mechanism of the action of gossypol. Using the random homozygous knockout approach of Li and Cohen (1), we developed a cell line resistant to killing by gossypol, but sensitive to methotrexate and doxorubicin. It showed stereospecific resistance to killing by (-) gossypol (ED(50) 4.9 microM) compared with wild type (ED(50) 2.0 microM). The resistant and wild-type cells were equally sensitive to (+) gossypol (ED(50) 8.8 and 8.4 microM, respectively), methotrexate, and doxyrubicin. We conclude that gossypol affects cells by a stereospecific pathway for (-) gossypol, possibly related to its selective effects, and a nonstereospecific pathway for (+) gossypol and higher concentrations of (-) gossypol. Further knowledge about the stereospecific pathway may lead to new therapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12037129     DOI: 10.1177/153537020222700605

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  8 in total

1.  Proapoptotic protein Smac mediates apoptosis in cisplatin-resistant ovarian cancer cells when treated with the anti-tumor agent AT101.

Authors:  Wenbin Hu; Fang Wang; Jingsheng Tang; Xinyu Liu; Zhu Yuan; Chunlai Nie; Yuquan Wei
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

Review 2.  Bcl-2 antagonists: a proof of concept for CLL therapy.

Authors:  Kumudha Balakrishnan; Varsha Gandhi
Journal:  Invest New Drugs       Date:  2013-08-02       Impact factor: 3.850

Review 3.  Small-molecule inhibitors reveal a new function for Bcl-2 as a proangiogenic signaling molecule.

Authors:  Benjamin D Zeitlin; Jacques E Nör
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

Review 4.  Targeting the apoptosis pathway in hematologic malignancies.

Authors:  Shadia Zaman; Rui Wang; Varsha Gandhi
Journal:  Leuk Lymphoma       Date:  2014-02-04

5.  Synthesis and evaluation of Apogossypol atropisomers as potential Bcl-xL antagonists.

Authors:  Jun Wei; Michele F Rega; Shinichi Kitada; Hongbin Yuan; Dayong Zhai; Prabhakar Risbood; Herbert H Seltzman; Charles E Twine; John C Reed; Maurizio Pellecchia
Journal:  Cancer Lett       Date:  2008-09-07       Impact factor: 8.679

6.  Enhancing drug accumulation in Saccharomyces cerevisiae by repression of pleiotropic drug resistance genes with chimeric transcription repressors.

Authors:  Alexander Stepanov; Karin C Nitiss; Geoffrey Neale; John L Nitiss
Journal:  Mol Pharmacol       Date:  2008-05-09       Impact factor: 4.436

Review 7.  Oxidative stress by targeted agents promotes cytotoxicity in hematologic malignancies.

Authors:  Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2009-05       Impact factor: 8.401

8.  Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models.

Authors:  M A Jarzabek; V Amberger-Murphy; J J Callanan; C Gao; A M Zagozdzon; L Shiels; J Wang; K L Ligon; B E Rich; P Dicker; W M Gallagher; J H M Prehn; A T Byrne
Journal:  Br J Cancer       Date:  2014-11-06       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.